Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kataja

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Combination of cisplatin and interferon-alpha 2a (Roferon-A) in patients with non-small cell lung cancer (NSCLC). An open phase II multicentre studyV Kataja, A Yap
Lancet (London, England)|March 2, 1996
Hypersensitivity reactions associated with 5- hydroxytryptamine(3)-receptor antagonists: a class effect?V Kataja, K M de Bruijn
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case reportK Pulkkanen, V Kataja, R Johansson
Experientia|December 15, 1984
Parenteral soya bean fat emulsions potentiate the hepatotoxicity of E. coli endotoxin in suckling ratsK M Heinonen, V Kataja, M Laitinen
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|July 1, 1994
c-erbB-2 oncogene expression in salivary gland tumoursV Kärjä, S Syrjänen, V Kataja, et al.
Anticancer Research|January 12, 2000
Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective studyM Eskelinen, V Kataja, E Hämäläinen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingI T Jantunen, V V Kataja, T T Muhonen
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapyI T Jantunen, V V Kataja, R T Johansson
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|May 4, 2005
Recurrences after immediate reconstruction in breast cancerP Mustonen, V Kataja, M Berg, et al.
Journal of Clinical Epidemiology|June 9, 1999
Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias?S Männistö, P Pietinen, M Virtanen, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Combination of cisplatin and interferon-alpha 2a (Roferon-A) in patients with non-small cell lung cancer (NSCLC). An open phase II multicentre studyV Kataja, A Yap
Lancet (London, England)|March 2, 1996
Hypersensitivity reactions associated with 5- hydroxytryptamine(3)-receptor antagonists: a class effect?V Kataja, K M de Bruijn
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case reportK Pulkkanen, V Kataja, R Johansson
Experientia|December 15, 1984
Parenteral soya bean fat emulsions potentiate the hepatotoxicity of E. coli endotoxin in suckling ratsK M Heinonen, V Kataja, M Laitinen
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|July 1, 1994
c-erbB-2 oncogene expression in salivary gland tumoursV Kärjä, S Syrjänen, V Kataja, et al.
Anticancer Research|January 12, 2000
Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective studyM Eskelinen, V Kataja, E Hämäläinen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingI T Jantunen, V V Kataja, T T Muhonen
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapyI T Jantunen, V V Kataja, R T Johansson
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|May 4, 2005
Recurrences after immediate reconstruction in breast cancerP Mustonen, V Kataja, M Berg, et al.
Journal of Clinical Epidemiology|June 9, 1999
Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias?S Männistö, P Pietinen, M Virtanen, et al.
Pageof 6